Anaplastic large-cell lymphoma (ALCL) is a rare large-cell malignant non-Hodgkin\'s lymphoma and accounts for 10%--15% of pediatric non-Hodgkin\'s lymphoma. Systemic ALCL manifesting as isolated skin abscess with no hepatomegaly or lymphadenopathy in the pediatric age group is very rare.

A 4-year-old boy, immunized for age, with no previous history of any serious illness presented with complaints of fever for 3 months and nonhealing abscess over the left gluteal region for 2 months. The child was initially seen by a general physician, a pediatrician, and a dermatologist for the skin lesion. Repeated incision and drainage and multiple courses of oral antibiotics had no effect. The abscess had progressed to a chronic ulcer when the child came to us. On examination, his anthropometric indices were appropriate for age, and he had no hepatosplenomegaly or lymphadenopathy. A 5 cm × 4 cm ulcer was seen over the left gluteal region \[[Figure 1](#F1){ref-type="fig"}\]. Blood investigations were normal. Gram stain and culture of the ulcer revealed no infectious etiology. Regular dressing and intravenous antibiotics had no healing effect on the ulcer. The child continued to have high-grade fever spikes, and all infectious etiological investigations were negative. Biopsy of the ulcer revealed cells with high mitotic index, and immunohistochemistry was suggestive of anaplastic lymphoma kinase (ALK)-positive ALCL \[[Figure 2](#F2){ref-type="fig"}\]. The metastatic evaluation revealed disseminated disease. The child became afebrile, 48 h after starting chemotherapy, and there was a complete healing of the ulcer after 2 cycles of chemotherapy \[[Figure 3](#F3){ref-type="fig"}\]. Isolated skin abscess as the presenting feature of disseminated ALCL in the pediatric population is rarely reported.
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Among all subtypes of non-Hodgkin\'s lymphoma, ALCL has been found to have more of primary cutaneous origin (10%).\[[@ref1]\] ALCL has two subtypes: primary cutaneous in which tumor is confined to the skin and systemic ALCL which presents with systemic disease. ALK-positive ALCL is a systemic disease and frequently involves the extranodal sites. The extranodal lesions involved are skin (21%), bone (17%), soft tissue (17%), lungs (11%), and liver (8%).\[[@ref2]\] In the pediatric population, 18%--25% of systemic ALCL will develop skin manifestations during the disease, and this has been considered as a poor prognostic marker.\[[@ref3]\] The common cutaneous manifestation of systemic ALCL is solitary or multiple red papules or nodules. Two-thirds of pediatric ALCLs present with systemic disease at diagnosis, including the extranodal tissues such as skin.\[[@ref4]\] Mora *et al*. had reported 52 pediatric patients with large-cell lymphoma, of them 9 showed skin involvement.\[[@ref5]\] Isolated cutaneous involvement by lymphomas is infrequent in children, and presentation can be confused with tuberculosis clinically. Only biopsy of the lesions would help in diagnosis.

Abscess is a common finding in the pediatric population, and hence, a chronic cutaneous lesion not responding to conventional treatment, with systemic manifestation such as fever, should alert the physician to look for other differential diagnoses. General physicians and dermatologists should be aware of the cutaneous manifestation of lymphomas in the pediatric population.
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